Background: Epidemiologic studies have shown increased risks of lung cancer among adults with low
INTRODUCTION
A potential benefit of higher selenium status on the risk of lung cancer has been reported, although the evidence is mixed and the benefit appears to be primarily limited to populations in which selenium status is low (1) (2) (3) . Within the United States, plasma selenium levels tend to be lower among residents of the southeast and among blacks than whites (4) , but prior studies of lung cancer and selenium have not included sizeable numbers of southerners or blacks. Herein we assess whether lung cancer risk might be related to selenium status within the Southern Community Cohort Study (SCCS), a prospective cohort of low-income black and white adults in the southeastern United States.
MATERIALS AND METHODS

Study population
The SCCS is a prospective cohort study being conducted to evaluate factors in the onset, outcome and disparities in cancer and other chronic diseases. Details of the methods have been described elsewhere (5) . In brief, during 2002-2009 adults were recruited from community health centers (CHCs) across a 12-state region (AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, VA, WV). Since CHCs provide basic and preventative health care in underserved areas, most of the enrollees, twothirds of whom reported themselves as black, were of low income (6) . Eligible participants were 40 to 79 years of age, had not been under treatment for cancer for at least the past year, and were English speaking. Participants signed a consent form approved by the Institutional Review Boards of Meharry Medical College and Vanderbilt University before submitting to a comprehensive computer-assisted interview by a trained interviewer on demographics, anthropometry, medical history, diet, physical activity, use of tobacco, alcohol, medications, and other characteristics. Biologic specimens (blood, saliva, and/or urine samples) were provided by approximately 90% of the cohort participants recruited from the CHCs, with 54% providing a blood sample. The blood samples were collected in two 10-ml tubes, one with EDTA preservative, from non-fasting study subjects upon their entry into the cohort at the CHCs. The vast majority (>95%) of blood samples were processed at Vanderbilt within 24 hours of collection and all samples have been kept in frozen storage at -80°C. The blood components were separated into aliquots of serum, plasma, red blood cells, buffy coat, and clot. One plasma aliquot was retrieved for the selenium assay described below.
Lung cancer case identification
Cases for the present study include all individuals diagnosed with lung cancer (International Classification of Diseases-Oncology [ICD-O-3] codes C340-C349) after entry into the SCCS, who also donated a blood specimen at baseline. Incident cancers were identified through linkage with the state cancer registries in the study area and from National Death Index (NDI) mortality records, with approximately 13% identified only from NDI (ICD10 codes C33-C34). Utilizing these methods, we identified 396 cases for the current analyses. We then excluded those individuals who identified as neither black nor white (n=3) or were missing smoking data (n=9), reducing our case count to 384.
Control selection
Two controls for each case were selected from SCCS participants who donated blood at baseline and had not been diagnosed with lung cancer at the time of the index case's diagnosis. Controls were individually matched on race, sex, age at enrolment (+/-2 years), date and place (CHC) of sample collection (+/-6 months), and menopausal status for women. Controls were also excluded if race was reported as neither black nor white (n=6) or if missing smoking data (n=15). After removing the remaining individuals who were now in a matched set without one case and at least one control, the final study population for the present study consisted of 372 cases and 716 matched controls.
Selenoprotein P (SEPP1) assay
SEPP1 is an extracellular protein produced in many tissues but primarily by the liver. SEPP1 transports selenium from the liver to extrahepatic tissues and protects against oxidative injury. It has been suggested to be the most appropriate measure of selenium nutritional status in healthy persons (7) (8) (9) .
From stored plasma samples donated by the lung cancer cases and controls at entry into the SCCS, we measured SEPP1 by ELISA, with daily calibration through a standard curve using purified human 
Statistical analysis
Plasma levels of SEPP1 were categorized into tertiles based on the distribution in the cases and controls combined. The Mantel-Haenszel chi-square test was used to assess differences in baseline characteristics of study participants by tertile of SEPP1 level.
To compute odds ratios (ORs) and 95% confidence intervals (CIs) of the association of SEPP1 levels and lung cancer risk we used conditional logistic regression with matched case-control sets as the strata. To test for a linear trend across antibody tertile of SEPP1 levels, a continuous variable was Effect modification by race and sex was evaluated by creating separate conditional logistic regression models for each category (black and white, and male and female, respectively), and by evaluating the interaction term using the likelihood ratio test. Effect modification by smoking status was evaluated through separate models for current smokers versus non-current smokers, using unconditional logistic regression, as we did not have the power to examine this association among the minority of matched sets that were concordant for smoking status. The unconditional logistic regression analyses were then adjusted for the previous matching variables of age, race, and sex, in addition to pack-years of smoking. To test for effect modification by smoking, we performed multivariable-adjusted conditional logistic regression in the entire population, with the inclusion of an interaction variable representing current smoking and median SEPP1 trend variable, and assessed the strength of this interaction by the likelihood ratio test.
To minimize the potential of reverse causality -whereby illness itself decreases, or leads to lower, SEPP1 levels -we performed two additional sets of analyses. First, we compared differences in mean SEPP1 levels among the cases by stage at diagnosis (localized, regional, or distant cancer), and then re-performed the same conditional logistic regression as described above, excluding the 51% of cases (and their matched controls) with more severe (i.e., distant) disease. Secondly, we performed the same analyses in two sub-sets of the study population, the first excluding those cases and their matched controls diagnosed within one year of blood draw, and the second excluding those cases and their matched controls diagnosed within two years of blood draw, to see if the associations between SEPP1 and lung cancer risk changed with lengthening the average time interval between blood sampling and cancer diagnosis.
.All statistical analyses were performed using SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
Comparing study participants by level of plasma SEPP1 in tertiles, blacks, women, younger individuals (40-49 years old), and individuals of normal weight (BMI of 18.3-24.9) were significantly more likely to be categorized in the lower third than whites, men, individuals over 50, and overweight and obese individuals respectively (Table 1) . Mean SEPP1 levels were significantly lower among blacks than whites (5.02 vs. 5.45, P<0.0001). When the association between race and SEPP1 tertile was assessed via odds ratios, the crude ORs, relative to tertile 3 (T3), for decreasing SEPP1 tertiles 2 and 1 among blacks vs whites were 1.7 and 2.5, respectively, so that the blacks had two and one-half the odds of having SEPP1 levels in the lowest tertile (T1) than whites (data not shown). Overall, decreasing levels of plasma SEPP1 were associated with an increasing risk of lung cancer among blacks (P for trend = 0.0006); the smoking-adjusted OR comparing those in the low vs. high tertiles (T1 vs. T3) of SEPP1 was 2.4 (95% CI = 1.5 to 3.0) ( Table 2 ). This pattern was not seen among whites (P for trend = 0.69; OR comparing T1 vs T3 of 1.1 [95% CI = 0.6 to 2.1]), although the interaction terms of SEPP1 level and race did not quite reach significance (P for interaction = 0.10).
When examining the association of SEPP1 level and lung cancer risk by smoking status, the association appeared slightly stronger among non-current smokers (P for trend = 0.004; OR comparing T1 vs. T3 of 2.6 [95% CI = 1.3 to 5.0]) than among current smokers (P for trend = 0.02; OR comparing T1 vs. T3 of 1.6 [95% CI = 1.0 to 2.3]) ( Table 3) .
To examine the possibility that the associations observed were due to reverse causality, as might happen if the development of lung cancer may decrease SEPP1 levels, we performed sensitivity analyses, comparing the entire population to the sub-group of cases (and their matched controls) whose diagnoses came at least one year or two years after blood draw (Supplementary Table 1 Table   2 ). The associations remained essentially unchanged for blacks, but the black-white difference was again diminished. In this population of primarily low-income blacks and whites in the southeast United States, low SEPP1 levels were associated with increased risk of lung cancer, with the effect seen primarily among blacks, whose odds of having low SEPP1 tertile levels were more than twice as high than for whites. As SEPP1 has been suggested to be the most sensitive predictor of selenium nutritional status (9), the present study supports and is consistent with the previous literature on selenium and lung cancer, for which the majority of studies find elevated risks among those with low selenium blood levels, particularly for populations where overall selenium nutriture is low (1,2) . This is the first investigation, however, to include substantial numbers of blacks, the first conducted across a broad area of the southeast where soil selenium availability tends to be lower than in other regions of the United States, as well as the first to assess SEPP1 as the selenium biomarker, in lung cancer risk. The findings of lower selenium status among blacks than whites, combined with an apparently stronger link to lung cancer risk among blacks than whites, raise the possibility that low selenium status may contribute to the higher incidence and mortality among black than white American men even though total tobacco consumption is lower among blacks (11-13). This hypothesis is particularly supported in our population, where black lung cancer cases had accumulated on average one-third lower the amount of pack years than white lung cancer cases at baseline (means of 30.2 and 51.7, respectively).
The association between risk of lung cancer and selenium intake and/or status appears to be complex, with our and other data pointing towards an elevated risk among those of low selenium nutriture. The dose-response relation appears to be nonlinear, however, possibly best described by a U-shaped curve with declining lung cancer risk as selenium deficiencies are corrected but flattening and then rising lung cancer incidence at the highest selenium levels (1-3). The study subjects in the SCCS, particularly blacks, tend to be in the low to middle portions of such a curve, likely enhancing our ability to show a significant association with higher lung cancer risk among those with the lowest selenium status. Ours is the first study to suggest a potentially greater impact of low selenium status on blacks than whites, thus caution is required in interpretation of the racial differential, especially since there was some diminution of the black-white difference when cases diagnosed within two years of cohort entry were excluded from the analysis. Nevertheless, the difference between SEPP1 levels in blacks and whites was striking, with low levels considerably more prevalent among blacks than whites. Prior research using NHANES assays of serum selenium (not SEPP1) have revealed lower mean levels among blacks than whites nationally (4) . Within an independent sample of over 380 SCCS study subjects, we also have found mean plasma selenium levels to be lower among blacks than whites, but the differential for elemental selenium was not as great as the differential for SEPP1, suggesting that the selenoprotein may be a stronger distinguisher of racial differences in selenium status (14) .
Findings from observational studies such as ours are subject to the potential influences of bias, confounding and chance, although confounding by socioeconomic and health care status that has afflicted many black-white comparisons is minimized by the design of the SCCS, where both blacks and whites are of very similar, mostly low, education and income and where all study subjects were (17) (18) (19) (20) . 21). Hence the randomized trial data cannot rule in or out a modest impact of selenium supplementation on lung cancer risk, but tend to be consistent with a potential near-term benefit when the supplements correct mild selenium deficiencies and no benefit (or a slight increase) in lung cancer risk when the supplements are provided to fully selenium nourished groups. None of the trials enabled adequate assessment of selenium supplementation among blacks.
This cohort study of lung cancer in relation to SEPP1 has a number of strengths and weaknesses which temper interpretation of the findings. Limitations include the modest total number of 372 lung cancer cases, with only one third among whites, limiting subgroup analyses, the relatively short follow up (maximum 9 years) of the cohort precluding precise evaluation of ORs across groups defined by time since blood draw, the one-time collection of blood specimens at cohort entry, population coverage primarily limited to low-income adults, and the lack of data on this population on genetic variants associated with selenium of SEPP1 metabolism. While only 50% of our cases were known adenocarcinomas or squamous cell cancers, when examining the race-specific SEPP1 association with lung cancer separately for these two histologies, we found no appreciable differences from the main findings (data not shown). Additionally, lung cancer cases in the current study are a sub-set of all lung cancer cases in the SCCS, as we could only include those individuals who donated a blood specimen at baseline. However, the demographic and socio-economic characteristics of cases in the current study are generally representative of the cases in the SCCS overall, although the cases in the present study were more likely to be white (35% vs. 30%) but less likely to both have a family income of $15,000 or more (28% vs. 34%) or to have achieved a high school education or more (50% vs. 58%) than the average SCCS lung cancer case. Strengths are more numerous and include the well- characterized underlying SCCS population with large numbers of blacks and whites with very similar backgrounds enhancing the internal validity of black-white comparisons, the prospective follow up and systematic ascertainment of lung cancer cases avoiding problems inherent in case-control studies, the selection of SCCS participants closely matched on demographic as well as blood collection factors as controls, and the novel measurement of SEPP1, the major selenium protein and a potentially promising biomarker. While the limitations of observational studies such as ours preclude making etiologic inferences, the findings are suggestive of a potentially greater impact upon lung cancer risk of low selenium status among blacks than whites and warrant additional investigation to confirm whether the patterns seen in this southeastern underserved population may exist more broadly. 
